Traws Pharma, Inc.

TRAWReported to SECin USCIK 0001130598Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 10. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 10
Form 4 lines at Traws Pharma, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Pauza Charles DavidChief Science Officer VirologyAwardnothing paid97,000 sharesJul 16, 2026Pauza Charles DavidChief Science Officer Virologynothing paidAward · Jul 16Award97,000Jul 16, 2026
Savchuk NikolayChief Operating OfficerAwardnothing paid93,000 sharesJul 15, 2026Savchuk NikolayChief Operating Officernothing paidAward · Jul 15Award93,000Jul 15, 2026
CAUTREELS WERNER—Awardnothing paid14,150 sharesJul 15, 2026CAUTREELS WERNERnothing paidAward · Jul 15Award14,150Jul 15, 2026
Parker Charles NolanChief Financial OfficerAwardnothing paid90,000 sharesJul 14, 2026Parker Charles NolanChief Financial Officernothing paidAward · Jul 14Award90,000Jul 14, 2026
Redfield RobertChief Medical OfficerAwardnothing paid84,000 sharesJul 14, 2026Redfield RobertChief Medical Officernothing paidAward · Jul 14Award84,000Jul 14, 2026